Supernormal Greens Shifts Focus to Medicinal Plant Production in Sweden
Swedish vertical farm Supernormal Greens - Ljusgarda has transitioned over ten medicinal plant species into large-scale production, moving beyond leafy greens. Co-founder Erik Lundgren highlights a strategy emphasizing compound density over fresh biomass, with current species including Ocimum sanctum and Plantago lanceolata. The company employs precision elicitation to enhance active compounds for pharmaceutical and cosmetic applications, indicating a shift in performance metrics from weight to functional potency.

Supernormal Greens - Ljusgarda has pivoted from lettuce to large-scale production of medicinal plants, transitioning over ten species from research to commercial viability. Co-founder Erik Lundgren details a process combining ethnobotany and modern science to optimize for compound density rather than fresh biomass.
Current species under production include Ocimum sanctum, Plantago lanceolata, and Borago officinalis. The company utilizes precision elicitation to activate plants' natural defenses, enhancing high-value compounds for various applications. This shift also changes performance metrics from weight to functional potency, focusing on the concentration and reproducibility of bioactive compounds.




Comments